Vimarsana
Biggest News Aggregation in the World

Profr Krishna Kumar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Profr Krishna Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Profr Krishna Kumar Today - Breaking & Trending Today

IIT Madras to offer 4 year BS programme in medical sciences and engineering - Vimarsana News

IIT Madras to offer 4 year BS programme in medical sciences and engineering

The admission procedure will be through IISER Aptitude Test (IAT). Candidates must have cleared Class 12 (or equivalent) examination with science stream in 2022 or 2023 from any board recognized by Council of Boards of Department Education in India.

Indomethacin shows efficacy in treating hospitalised COVID-19 patients: IIT-M - Vimarsana News

Indomethacin shows efficacy in treating hospitalised COVID-19 patients: IIT-M

The research have recently been published in the prestigious peer-reviewed journal Nature Scientific Reports

Indomethacin highly effective in treating COVID-19 infection: Study - Vimarsana News

Indomethacin highly effective in treating COVID-19 infection: Study

The study was conducted by Dr Rajan Ravichandran, Director Nephrology, MIOT Hospitals and Prof R Krishna Kumar, Institute Professor, IIT Madras in India

Indomethacin highly effective in treating covid infection: Study - Vimarsana News

Indomethacin highly effective in treating covid infection: Study

The study was conducted by Dr Rajan Ravichandran, Director Nephrology, MIOT Hospitals and Prof R Krishna Kumar, Institute Professor, IIT Madras in India

Researchers to study Indomethacin's impact on oxygen need in Covid patients - Vimarsana News

Researchers to study Indomethacin's impact on oxygen need in Covid patients

Researchers to study Indomethacin’s impact on oxygen need in Covid patients April 28, 2021 × After seeing encouraging results in a pilot study done last year, Indian researchers are now planning to conduct a randomised control trial (RCT) to understand the efficacy and safety of indomethacin in providing faster symptomatic relief and reduction in oxygen requirement in Covid-19 patients. Indomethacin is a nonsteroidal, anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, stiffness, and swelling caused by rheumatoid arthritis. In December 2020, Medrxiv published a preprint of ...